MRNS

Marinus Pharmaceuticals (MRNS)

About Marinus Pharmaceuticals (MRNS)

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

Details

Daily high

$1.76

Daily low

$1.66

Price at open

$1.67

52 Week High

$11.26

52 Week Low

$1.05

Market cap

96.4M

Dividend yield

0.00%

Volume

356,087

Avg. volume

744,286

P/E ratio

-.66

Marinus Pharmaceuticals News